#Spain #Barcelona #Advanced Therapies #Phacilitate

Advanced Therapies Europe 2025: A New Format for Networking and Innovation

The Advanced Therapies Europe 2025 conference is set to take place in Barcelona from September 2nd to 4th at the luxurious Hotel Arts, Ritz-Carlton. This will be the first edition hosted in Barcelona, presenting an exciting opportunity for professionals in the field of biotechnology and advanced therapies.

This year's event brings a fresh perspective with a focus on high-impact networking and a meticulously curated experience. With a strict cap of 500 attendees, the aim is to encourage valuable interactions that can drive innovation within the industry. The event organizers have emphasized the importance of creating opportunities for attendees to engage deeply with one another, fostering an environment where critical conversations can occur.

Why the Focus on Connections?

In an age where digital communication can often overshadow personal interactions, the Advanced Therapies Europe conference is a response to the need for meaningful engagement. The limited attendee count allows for more intimate discussions, ensuring that participants can connect on both professional and personal levels. This emphasis on face-to-face networking is designed to accelerate collaboration and spark new ideas critical for the advancement of cell and gene therapies.

Key Highlights of the Event

The event's agenda has been crafted to address key topics shaping the future of biotechnology. Attendees will explore various subjects, including:

• - Investment and market trends driving the industry.
• - Strategies for successful manufacturing and scaling up processes.
• - Clinical development pathways and commercialization challenges.
• - Insight into emerging technologies and the dynamic global regulatory environment.

A rich array of content will feature in-depth workshops, interactive track sessions, and focused roundtable discussions, all designed to encourage open dialogue and collaborative problem-solving among participants. Leading voices in the sector will also provide unique insights through presentations and panels, making this a must-attend event for anyone serious about advancing their knowledge and professional connections in the field of biotechnology.

Notable Speakers and Sessions

The lineup of confirmed speakers is impressive, including:

• - Miguel Forte, CEO of Kiji Therapeutics
• - Thomas Carlsen, CEO of Novo Nordisk Cellerator
• - Ase Rosenqvist, representing Johnson & Johnson's Nordic Cell Therapy Business Unit
• - Eleuterio Lombardo, Director of Cell Therapy Characterization at Takeda
• - Angela Vollstedt, Director of Global R&D Cell & Gene Therapies Portfolio at Novartis

These experts will lead discussions on critical topics, providing invaluable perspectives and insights into both the challenges and opportunities facing the sector.

Special Features of the Conference

Additionally, the conference will host returning cornerstone events, including the Women in Advanced Therapies Congress and the Investment Summit, both platforms designed to promote mentorship and alignment on strategic goals within the sector. The Innovation Exchange will also return, showcasing breakthrough companies in biotech and fostering connections with investors poised to shape the industry's future.

Ingerid Sorgaard, Content Director at Phacilitate, remarked, "We have reimagined this year's event to be even more dynamic and interactive. It's not just about sharing content; it's about facilitating essential conversations in conducive environments."

Get Involved

Applications to attend Advanced Therapies Europe 2025 are now open. With just 500 spots available and Super Early Bird pricing in place until April 18th, those interested are encouraged to apply early.

For further details, visit the official site here.

In a world where innovation is rapidly advancing, the Advanced Therapies Europe 2025 conference promises to be a landmark event, paving the way for meaningful progress and collaboration within the field of advanced therapies.

This conference embodies the spirit of connection and is set to redefine how the biotechnology community interacts—and innovates—together in the years ahead.